ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,604Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 161

$277K Total Retail Price of All Prescriptions

Rank: 11 out of 161

378 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

9% of this provider’s 378 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,154 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 472 451 1 1
OMEPRAZOLE 399 368 2 3
LISINOPRIL 382 372 3 4
SIMVASTATIN 278 240 4 2
AMLODIPINE BESYLATE 209 207 5 5
FUROSEMIDE 181 181 6 7
METOPROLOL TARTRATE 179 179 7 12
WARFARIN SODIUM 161 150 8 8
POTASSIUM CHLORIDE 160 160 9 11
LOSARTAN POTASSIUM 156 156 10 17
ATENOLOL 148 133 11 19
TRAMADOL HCL 142 139 12 16
METOPROLOL SUCCINATE 139 139 13 13
SERTRALINE HCL 119 119 14 20
METFORMIN HCL 115 100 15 9
LOSARTAN-HYDROCHLOROTHIAZIDE 111 111 16 30
ATORVASTATIN CALCIUM 105 100 17 14
GABAPENTIN 101 93 18 15
CARVEDILOL 99 91 19 23
HYDROCHLOROTHIAZIDE 95 95 20 10
HYDROCODONE-ACETAMINOPHEN 94 93 S3 21 6
ADVAIR DISKUS 87 79 22 52
METFORMIN HCL ER 84 83 23 49
PRAVASTATIN SODIUM 81 81 24 22
RISPERIDONE 81 81 24 29
ALLOPURINOL 80 78 26 28
ZOLPIDEM TARTRATE 70 69 27 26
OXYBUTYNIN CHLORIDE 70 70 27 96
CITALOPRAM HBR 69 69 29 21
SPIRONOLACTONE 69 68 29 44
POLYETHYLENE GLYCOL 3350 68 62 31 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 60 32 37
RANITIDINE HCL 59 59 33 78
CYMBALTA 57 35 34 34
ROPINIROLE HCL 56 41 35 66
FLUTICASONE PROPIONATE 56 54 35 27
MELOXICAM 55 50 37 18
ALENDRONATE SODIUM 53 53 38 25
GLIMEPIRIDE 52 52 39 32
NABUMETONE 51 33 40 84
NEXIUM 50 31 41 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.